Agence France-Presse examines how two recent studies have “boosted morale” among HIV vaccine researchers who have struggled for decades to develop a viable vaccine to protect people from the virus.
At the launch of the Campaign to End Pediatric HIV/AIDS (CEPA) on Thursday, advocate Graca Machel urged African leaders to redirect state spending to prevent and treat HIV infections among women and children, Agence France-Presse reports. An estimated “1.8 million of the world’s two million [HIV-positive] children” live in Sub-saharan Africa, where “[m]other-to-child prevention and treatment coverage currently averages 30 to 40 percent against a target of 80 percent,” the news service writes (10/22).
The Observer examines the recent appeal by some health experts for an “overhaul of health spending in Africa,” which, they say, focuses on HIV/AIDS and overlooks other deadly diseases, such as diarrhea.
The Obama administration announced an end to a travel ban for HIV-infected travelers.
Lancet World Report Examines Undernutrition in Afghanistan A Lancet World Report examines the deadly toll undernutrition is having on the people of Afghanistan, where theÂ “issues of poverty and undernutrition have received curiously little attention: about a third of the population, more than 7 million people, are food insecure, according the…
The New York Times examines an HIV prevention program in China aimed at promoting blood screening that has led “more than 110,000 people” being test so far: “On any given night, in 14 cities around the country, hundreds of people flock to makeshift blood collection centers in bars, bathhouses and apartments where workers test for syphilis and HIV, the virus that causes AIDS.”
Foreign Policy examines “a revolutionary idea for how to remake charity in the 21st century [that] is taking off: philanthrocapitalism.” The magazine writes: “Unlike their colleagues in government bureaucracies and tried-and-true NGOs, the philanthrocapitalists are a nimble, business-minded stock.”
A Lancet study published online Tuesday validates the safety of administering first-line antiretroviral therapy (ART) to patients with HIV without routine toxicity and efficacy lab tests, “[b]ut tests of immune-system function might still be a good idea to monitor the progression of the disease and guide the second year of treatment,” HealthDay/U.S. News & World Report reports. Patients in Africa “often receive [HIV] drug treatment … without routine laboratory monitoring,” according to the article.
Also In Global Health News: Rotavirus Vaccine; Guinea Worm Eradication; Health Systems; Zulu King Calls For Male Circumcision
West African Group Calls For Governments To Vaccinate Children Against Rotavirus The West African Rotavirus Advisory Board is calling on governments to vaccinate children against rotavirus, IRIN reports. At a recent meeting in Dakar, Senegal, which was “financed by GlaxoSmithKline, makers of one of two rotavirus vaccines” the board issued…
News Outlets Examine Reaction To Uganda’sÂ Anti-Gay Legislation Effect On HIV/AIDS Efforts The Daily Monitor reports on a statement released Friday by U.S. Senator Russ Feingold (D-Wis.), chair of the Senateâ€™s Committee on Africa, on Uganda’s anti-gay legislation. “Its passage would hurt the close working relationship between our two countries, especially…